Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of ZX-8177 in Patients With Advanced Solid Tumors
Clinical trial NCT07310134 · RECRUITING
Trial details
- NCT number
- NCT07310134
- Sponsor
- Nanjing Zenshine Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-26
- Primary completion
- 2026-11-30
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.